Bacterial Urinary Infection — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for bacterial urinary infection. 17 active patents protecting 3 drugs from 2+ originators. First major cliff: 2027. Daily refresh.

3
Approved drugs
17
Active US patents
70/100
Avg vulnerability
—
Annual revenue covered

Originators in Bacterial Urinary Infection

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Pfizer) 15 patents Novartis 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating bacterial urinary infection. Each bar = one year. Y-axis scaled to peak year (6 patents).

2
26
2
27
1
28
5
30
6
34

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Tobi
tobramycin
 Novartis 2 72 — 2028-09-12
Vibramycin
doxycycline
 Generic (originally Pfizer) 1 80 — 2027-12-19

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
7749532 Vibramycin method of use 80 2027-12-19
8869794 Tobi method of use 75 2028-09-12
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
10207066 Tobi method of use 68 2030-11-04
8357394 Amoxil formulation 65 2026-12-08
11135172 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10238606 Amoxil formulation 42 2034-02-12
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11
9498445 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12
9050263 Amoxil method of use 62 2034-02-12
8357394 Amoxil formulation 65 2026-12-08

Related